Open AccessComplete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
Author(s) -
Driessen Christoph,
Noppen Christoph,
Boonen Georg,
Drewe Juergen
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4903
Subject(s) - polycythemia vera , medicine , alpha interferon , interferon , interferon alfa , gastroenterology , immunology
Low‐dose interferon‐α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high‐risk polycythemia vera patients.